advertisement

Oculus

Journal of Ocular Pharmacology and Therapeutics 32

Showing records 1 to 25 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Hwang HB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511
82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Salimi A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420
82048 Antiglaucoma EP Agonists: A Long Road That Led Somewhere
Woodward DF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 469-474
82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Uchida T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541
82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Salimi A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420
82588 ISOPT Hot Topic Panel Discussion on Glaucoma
Blumenthal EZ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 441-446
82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Salimi A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Kim SY
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Lu F
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Ueta T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541
82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Winter A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420
82588 ISOPT Hot Topic Panel Discussion on Glaucoma
Cordeiro MF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 441-446
82048 Antiglaucoma EP Agonists: A Long Road That Led Somewhere
Wang JW
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 469-474
82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Li C
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420
82588 ISOPT Hot Topic Panel Discussion on Glaucoma
Shmetterer L
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 441-446
82048 Antiglaucoma EP Agonists: A Long Road That Led Somewhere
Stamer WD
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 469-474
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Kawata H
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Ohn K
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511
82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Honjo M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541
82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Harasymowycz P
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420
82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541
82588 ISOPT Hot Topic Panel Discussion on Glaucoma
Levkovitch Verbin H
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 441-446
82048 Antiglaucoma EP Agonists: A Long Road That Led Somewhere
Lütjen-Drecoll E
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 469-474
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Tanaka Y
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550

Issue 20-4

Select Issue


advertisement

Oculus